This document is an excerpt from the EUR-Lex website
Document 62015TN0214
Case T-214/15: Action brought on 23 April 2015 — Novartis v OHIM — Meda (Zymara)
Case T-214/15: Action brought on 23 April 2015 — Novartis v OHIM — Meda (Zymara)
Case T-214/15: Action brought on 23 April 2015 — Novartis v OHIM — Meda (Zymara)
OJ C 205, 22.6.2015, p. 40–40
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
22.6.2015 |
EN |
Official Journal of the European Union |
C 205/40 |
Action brought on 23 April 2015 — Novartis v OHIM — Meda (Zymara)
(Case T-214/15)
(2015/C 205/53)
Language in which the application was lodged: English
Parties
Applicant: Novartis AG (Basel, Switzerland) (represented by: M. Douglas, lawyer)
Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM)
Other party to the proceedings before the Board of Appeal: Meda AB (Solna, Sweden)
Details of the proceedings before OHIM
Applicant: Other party to the proceedings before the Board of Appeal
Trade mark at issue: Community word mark ‘Zymara’ — Application for registration No 9 982 745
Procedure before OHIM: Opposition proceedings
Contested decision: Decision of the Fifth Board of Appeal of OHIM of 6 February 2015 in Case R 550/2014-5
Form of order sought
The applicant claims that the Court should:
— |
Annul the contested decision; |
— |
Order OHIM to pay the costs. |
Pleas in law
— |
The Board of Appeal has misinterpreted the goods which are ‘pharmaceutical preparations, namely preparations for the treatment of cancer’; |
— |
The Board of Appeal has incorrectly based its decision on spelling rules which are not existing; |
— |
The Board of Appeal has ignored arguments put forward with respect to the comparison of signs and, therefore, incorrectly held that the signs are phonetically similar only to a low degree; |
— |
The Board of Appeal has put too much wait on the word beginnings within the visual comparison. |